Suppr超能文献

心脏停搏期间心肌三磷酸腺苷的保存:技术比较

Preservation of myocardial ATP during cardioplegia: comparison of techniques.

作者信息

Catinella F P, Knopp E A, Cunningham J N

出版信息

J Cardiovasc Surg (Torino). 1984 Jul-Aug;25(4):296-303.

PMID:6480681
Abstract

Preservation of myocardial ATP enhances the heart's ability to resume normal function following aortic crossclamping (AXC). Preservation of this high energy substrate during 4 cardioplegia delivery techniques was evaluated and compared with changes occurring during 4 hours of continuous coronary perfusion. Dogs (31) were placed on cardiopulmonary bypass and transmural left ventricular biopsies obtained for control ATP measurements. Animals were then divided into five groups: Group I (n = 6): 4 hrs. of continuous coronary perfusion (CCP); Group II (n = 6): 3 hrs. continuous AXC, multidose blood cardioplegia (MBC); Group III (n = 6): 3 hrs. continuous AXC, multidose crystalloid cardioplegia (MCC); Group IV (n = 6): 2 hrs. intermittent AXC, single dose BC (SBC); Group V (n = 7): 2 hrs. continuous AXC, continuous perfusion BC (CBC). In each group, where applicable, myocardial biopsies were taken at 30 minute intervals during AXC, before and after cardioplegia injection, and 30 minutes following final unclamping and rewarming. Hearts in Group II (MBC) and V (CBC) showed greatest preservation of ATP stores (increases 1.1 +/- 1.2%, increases 1.8 +/- 0.9% respectively; p greater than .05) ATP levels rose as high as 23 +/- 2% (p less than .005) above control immediately following cardioplegia injection in Group II (MBC). Group IV showed poorest preservation of ATP (decreases 26 +/- 5%, p less than .01) with levels falling as much as 37 +/- 10% (p less than .01) during the period of AXC. Hearts in Group I (CCP) demonstrated a 15.6 +/- 7.5% decrease in ATP from control (p less than .05). Group III (MCC) also showed a steady decline in ATP declining 18 +/- 3% (p less than .005) from control. These data indicate that multidose blood and continuous-blood cardioplegia techniques will maintain normal myocardial ATP stores throughout the period of AXC. These groups actually show a slight rise in ATP as compared to 4 hrs. of continuous coronary perfusion.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

保存心肌三磷酸腺苷(ATP)可增强心脏在主动脉交叉钳夹(AXC)后恢复正常功能的能力。评估了在4种心脏停搏液灌注技术过程中这种高能底物的保存情况,并与持续冠状动脉灌注4小时期间发生的变化进行了比较。将31只狗置于体外循环下,并获取透壁左心室活检组织用于对照ATP测量。然后将动物分为五组:第一组(n = 6):持续冠状动脉灌注(CCP)4小时;第二组(n = 6):持续AXC 3小时,多剂量血液心脏停搏液(MBC);第三组(n = 6):持续AXC 3小时,多剂量晶体心脏停搏液(MCC);第四组(n = 6):间歇性AXC 2小时,单剂量血液心脏停搏液(SBC);第五组(n = 7):持续AXC 2小时,持续灌注血液心脏停搏液(CBC)。在每组中,在适用的情况下,在AXC期间每隔30分钟、心脏停搏液注射前后以及最终解除钳夹和复温后30分钟采集心肌活检组织。第二组(MBC)和第五组(CBC)的心脏显示出ATP储备的最大保存(分别增加1.1±1.2%,增加1.8±0.9%;p大于0.05)。在第二组(MBC)中,心脏停搏液注射后立即ATP水平比对照升高高达23±2%(p小于0.005)。第四组显示ATP的保存最差(降低26±5%,p小于0.01),在AXC期间水平下降多达37±10%(p小于0.01)。第一组(CCP)的心脏显示ATP比对照降低15.6±7.5%(p小于0.05)。第三组(MCC)也显示ATP稳步下降,比对照下降18±3%(p小于0.005)。这些数据表明,多剂量血液和持续血液心脏停搏液技术将在整个AXC期间维持正常的心肌ATP储备。与持续冠状动脉灌注4小时相比,这些组实际上显示出ATP略有上升。(摘要截断于250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验